Agenus reported $25.4M in Gross Profit on Sales for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Agenus AGEN:US $ 25.4M 6.02M
Amgen AMGN:US $ 5084M 407M
AstraZeneca AZN:LN 8.87B 244M
Bristol Myers Squibb BMY:US $ 9210M 33M
ChemoCentryx CCXI:US 5.25M 3.24M
CSL CSL:AU $ 3.45B 1.08B
Dynavax Technologies DVAX:US $ 173.1M 99.06M
Eli Lilly And LLY:US $ 5057.5M 680.4M
Gilead Sciences GILD:US $ 4818M 348M
GlaxoSmithKline GSK:LN 4.79B 1.34B
Glaxosmithkline GSK:US $ 4793M 1342M
Jiangsu Hengrui Me. 600276:CH CH 4.57B 75.78M
Johnson & Johnson JNJ:US $ 16101M 273M
Karyopharm Therapeutics KPTI:US $ 38.74M 7.5M
MacroGenics MGNX:US 23.6M 12.55M
Merck MRK:GR € 3459M 248M
Merk MRK:US $ 10895M 328M
Novartis NOVN:VX 9.34B 277M
Pfizer PFE:US $ 19071M 3420M
Regeneron Pharmaceuticals REGN:US $ 2560.1M 0.1M
Veracyte VCYT:US $ 47.83M 3.76M
YTE INCY:US $ 866.16M 170.14M